Ischemic Stroke Clinical Trial
Official title:
Acute Longitudinal Transcranial Magnetic Stimulation (TMS) After Stroke
Verified date | April 2015 |
Source | Nexstim Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The past 10 years of research in persons more than 6 months post stroke have shown certain
types of rehabilitation can help "re-wire" the brain. Transcranial magnetic stimulation
(TMS) can be used to monitor this re-wiring by mapping the brain's function (measuring brain
activity). Recent research suggests that TMS can be used for both prognosis (determining
future function) and to determine what type of rehabilitation therapy will work best after
stroke. The purposes of this research study are to: 1) determine changes in brain activity
during the first 6 months after stroke (to determine how the brain "re-wires"); 2) compare
changes in recovery of motor function with changes in brain re-wiring; 3) determine the
ability of TMS to "predict" functional outcome in the first 6 months after stroke.
The primary hypotheses are: 1) functional recovery will be correlated with TMS changes (as
measure motor threshold (MT), motor evoked potentials (MEPs) and recruitment curves; 2)
baseline TMS will predict future functional outcomes at 3 and 6 months.
Status | Terminated |
Enrollment | 5 |
Est. completion date | March 2014 |
Est. primary completion date | March 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years to 80 Years |
Eligibility |
Inclusion Criteria: - one sided ischemic stroke confirmed by radiology - 20-80 years old Exclusion Criteria: - hemorrhagic stroke - brainstem stroke - cerebellar stroke - thalamic stroke - seizure with the recent stroke - any history of uncontrolled seizure - history of epilepsy - pregnancy or planning on getting pregnant during the next year - MRI incompatibility (e.g. metal implants in body) - recent history (past year) of alcohol and drug abuse (due to lack of follow up) Other criteria include TMS exclusions: aneurysm clips, previous surgery over motor cortex, open craniotomy |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | Drake Rehabilitation Center | Cincinnati | Ohio |
Lead Sponsor | Collaborator |
---|---|
Nexstim Ltd |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | navigated transcranial magnetic stimulation examination and correlation with motor functional testing | Enrollment, week 2, week 4 , week 12 and week 24 post-stroke | No | |
Secondary | Safety of navigated transcranial magnetic stimulation examination | each examination | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 |